ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.
about
Imaging of oligodendrogliomaMR Imaging Biomarkers in Oncology Clinical TrialsPerfusion magnetic resonance imaging provides additional information as compared to anatomical imaging for decision-making in vestibular schwannoma.Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.Characterizing the Influence of Preload Dosing on Percent Signal Recovery (PSR) and Cerebral Blood Volume (CBV) Measurements in a Patient Population With High-Grade Glioma Using Dynamic Susceptibility Contrast MRIEffects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas.Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.Slice-accelerated gradient-echo echo planar imaging dynamic susceptibility contrast-enhanced MRI with blipped CAIPI: effect of increasing temporal resolution.Optimization of DSC MRI Echo Times for CBV Measurements Using Error Analysis in a Pilot Study of High-Grade Gliomas.The diagnostic accuracy of multiparametric MRI to determine pediatric brain tumor grades and types.Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice.Conventional and advanced magnetic resonance imaging in patients with high grade glioma.Imaging in neuro-oncology.Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
P2860
Q26768596-AED36231-7BAE-4CD7-BDD6-A93ABFE3237AQ30364608-5C387F85-AE52-4E41-AA4E-AEAF064EE523Q30380590-7D2B90F2-B595-46F8-941B-5E8280ADE386Q31153877-3ABD7FA3-A581-4434-9F60-96D3E5A2283CQ35771783-D0AE4935-3922-48E4-925A-3A30368E7B15Q38616514-E4C01DF9-3F84-44C3-B52A-EFD373FCAE83Q39051829-764C1C32-6C0A-4823-B83A-61D70F5071A7Q41594601-B5CC525F-3984-4268-8499-2A5551C46BCBQ43376098-B3802078-D18D-4F03-B7C8-E4E2BF380489Q47191283-1E53DF7B-FBB0-43C8-BDF7-CFC0DC3F443DQ47685939-B6296BD4-FDC9-4AB0-AD0F-A0E242AF49E7Q47951605-15957B60-3D62-43B4-B20B-32B93A85FDC7Q48269490-7249601C-2CEB-4834-BCBB-D6F0C886AB64Q50237668-A934BEE5-FEB3-4DF5-A0D7-E66B75AE3D84Q51416304-C71AB651-DDA1-49C4-B23E-4F7C9711B38BQ52562075-D3EEDF2D-40FF-4A84-A96C-F5CFC3124ABDQ54973707-385E3D7C-00CE-473A-8830-94C0D1723C97Q57177114-028F9F02-4B87-4CF7-9C78-DD97E530D039
P2860
ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
ASFNR recommendations for clin ...... erfusion imaging of the brain.
@ast
ASFNR recommendations for clin ...... erfusion imaging of the brain.
@en
type
label
ASFNR recommendations for clin ...... erfusion imaging of the brain.
@ast
ASFNR recommendations for clin ...... erfusion imaging of the brain.
@en
prefLabel
ASFNR recommendations for clin ...... erfusion imaging of the brain.
@ast
ASFNR recommendations for clin ...... erfusion imaging of the brain.
@en
P2093
P2860
P356
P1476
ASFNR recommendations for clin ...... perfusion imaging of the brain
@en
P2093
American Society of Functional ...... NR Clinical Practice Committee
J Boxerman
M Shiroishi
M Wintermark
T Kaufmann
P2860
P304
P356
10.3174/AJNR.A4341
P50
P577
2015-04-23T00:00:00Z